Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Nov | Oct | Sep | Aug | July | Jun | May | Apr | Mar | Feb  | Jan

	Dr. Reddy's announces USFDA approval for Citalopram Hydrobromide tablets October 29, 2004
	Novo Nordisk terminates further clinical development of Balaglitazone (DRF 2593) out-licensed by Dr. Reddy's October 27, 2004
	Dr. Reddy's Q2 FY05 revenue at Rs.5,407 million; Net income at Rs.517 million October 26, 2004
	Dr. Reddy's Announces Litigation on ANDA for Finasteride tablets 1 mg October 1, 2004

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.